DE69532819D1 - Kohlenhydrate derivate und die enthaltende zusammensetzungen - Google Patents

Kohlenhydrate derivate und die enthaltende zusammensetzungen

Info

Publication number
DE69532819D1
DE69532819D1 DE69532819T DE69532819T DE69532819D1 DE 69532819 D1 DE69532819 D1 DE 69532819D1 DE 69532819 T DE69532819 T DE 69532819T DE 69532819 T DE69532819 T DE 69532819T DE 69532819 D1 DE69532819 D1 DE 69532819D1
Authority
DE
Germany
Prior art keywords
containing compositions
carbohydrate derivatives
derivatives
carbohydrate
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69532819T
Other languages
English (en)
Other versions
DE69532819T2 (de
Inventor
Lars Persson
Nicola Rehnberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BIONERIS LIDINGOE AB
Original Assignee
BIONERIS LIDINGOE AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BIONERIS LIDINGOE AB filed Critical BIONERIS LIDINGOE AB
Publication of DE69532819D1 publication Critical patent/DE69532819D1/de
Application granted granted Critical
Publication of DE69532819T2 publication Critical patent/DE69532819T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02Acyclic radicals, not substituted by cyclic structures
    • C07H15/04Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • C07H11/04Phosphates; Phosphites; Polyphosphates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin B12

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DE69532819T 1994-09-20 1995-09-15 Kohlenhydrate derivate und die enthaltende zusammensetzungen Expired - Fee Related DE69532819T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9403137 1994-09-20
SE9403137A SE9403137D0 (sv) 1994-09-20 1994-09-20 Derivatives of carbohydrates and compositions containing them
PCT/SE1995/001044 WO1996009310A1 (en) 1994-09-20 1995-09-15 Derivatives of carbohydrates and compositions containing them

Publications (2)

Publication Number Publication Date
DE69532819D1 true DE69532819D1 (de) 2004-05-06
DE69532819T2 DE69532819T2 (de) 2005-02-03

Family

ID=20395291

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69532819T Expired - Fee Related DE69532819T2 (de) 1994-09-20 1995-09-15 Kohlenhydrate derivate und die enthaltende zusammensetzungen

Country Status (8)

Country Link
US (1) US6310042B1 (de)
EP (1) EP0793668B1 (de)
JP (1) JPH10506389A (de)
AT (1) ATE263179T1 (de)
AU (1) AU3580995A (de)
DE (1) DE69532819T2 (de)
SE (1) SE9403137D0 (de)
WO (1) WO1996009310A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009523922A (ja) * 2006-01-18 2009-06-25 インビスタ テクノロジーズ エス エイ アール エル 織物以外のポリマー組成物および方法
US20090181078A1 (en) 2006-09-26 2009-07-16 Infectious Disease Research Institute Vaccine composition containing synthetic adjuvant
PT2486938T (pt) 2006-09-26 2018-06-12 Infectious Disease Res Inst Composição para vacina contendo adjuvante sintético
TWI494125B (zh) 2009-06-05 2015-08-01 Infectious Disease Res Inst 合成的葡萄吡喃糖基脂質佐劑
AU2012243039B2 (en) 2011-04-08 2017-07-13 Immune Design Corp. Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses
EA034351B1 (ru) 2012-05-16 2020-01-30 Иммьюн Дизайн Корп. Трехкомпонентная вакцина против впг-2 и способы ее применения
BR112015025709A2 (pt) 2013-04-18 2017-07-18 Immune Design Corp monoterapia com gla para uso em tratamento de câncer
US9463198B2 (en) 2013-06-04 2016-10-11 Infectious Disease Research Institute Compositions and methods for reducing or preventing metastasis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1568127C3 (de) * 1966-06-15 1974-03-21 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur Herstellung von Hexose-1,6-bzw. Pentose-1,5-diphosphaten
US3652743A (en) * 1968-03-26 1972-03-28 Dow Chemical Co Preparation of hydroxyalkyl phosphates and polyphosphates
WO1990001938A1 (en) * 1988-08-19 1990-03-08 The Australian National University Phosphosugar-based anti-inflammatory and/or immunosuppressive drugs
ES2019839A6 (es) * 1990-05-10 1991-07-01 Europharma Sa Procedimiento de obtencion de derivados polifosforilados de galactosa con actividad insulinica.
EP0485614B1 (de) * 1990-05-21 1997-08-13 Toppan Printing Co., Ltd. Cyclodextrinderivat
GB9205800D0 (en) * 1992-03-17 1992-04-29 British Tech Group Treatment of fibrotic disorders

Also Published As

Publication number Publication date
ATE263179T1 (de) 2004-04-15
AU3580995A (en) 1996-04-09
US6310042B1 (en) 2001-10-30
WO1996009310A1 (en) 1996-03-28
EP0793668A1 (de) 1997-09-10
JPH10506389A (ja) 1998-06-23
EP0793668B1 (de) 2004-03-31
SE9403137D0 (sv) 1994-09-20
DE69532819T2 (de) 2005-02-03

Similar Documents

Publication Publication Date Title
CA2356380A1 (en) Immunosuppressive effects of pteridine derivatives
KR970006279A (ko) 약제학적 활성 성분으로서의 6-디메틸아미노메틸-1-페닐-사이클로헥산 화합물
DE69908819D1 (de) Glycopeptid-derivate und pharmazeutische zusammensetzungen, die sie enthalten
FR2708608B1 (fr) Dérivés de N-sulfonylbenzimidazolone, leur préparation, les compositions pharmaceutiques en contenant.
BG101250A (en) Salts of an anti-migraine indole derivative
FR2708606B1 (fr) Dérivés du N-phénylalkylindol-2-one, leur préparation, les compositions pharmaceutiques en contenant.
HUT59145A (en) Process for producing substituted azole derivatives and pharmaceutical compositions such compounds as active ingredient
BR9810495A (pt) Composição farmacêutica
HUP0003571A2 (hu) 6,9-Hídkötésű eritromicin-származékok
MD1560G2 (ro) Compuşi ciclici, compoziţii farmaceutice pe baza lor şi metode de tratament al infecţiilor sau bolilor provocate de retrovirusuri
DE69532819D1 (de) Kohlenhydrate derivate und die enthaltende zusammensetzungen
BR9503572A (pt) Composto composiçao farmaceutica e método de tratamento ou prevençao de uma doença
DE69931378D1 (de) Chinazolin derivate und therapeutische verwendungen davon
ES2188908T3 (es) Derivados de cis-3,4-cromano utiles para la prevencion o tratamiento de sindromes relacionados con el estrogenos.
FR2686513B1 (fr) Compositions pharmaceutiques aqueuses de cromoglycate sodique.
ATE218560T1 (de) Wasserlösliche ähnliche verbindungen und medicament-vorstufe von paclitaxel
TW366284B (en) Pharmaceutical antitussive composition of delta-receptor antagonist
ES2191170T3 (es) Nuevos (-)-enantiomeros de derivados de cis-3,4-cromano utiles en la prevencion y tratamiento de sindromes o enfermedades relacionadas con el estrogeno.
IL129627A0 (en) Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
IL111138A (en) Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia
FR2716193B1 (fr) Dérivés de 1[2-(1h-inden-3-yl)ethyl]-4-(naphtalen-1-yl)piperazine, leur préparation et leur application en thérapeutique.
ES2184285T3 (es) Compuestos farmaceuticos que contienen diclorhidrato de cinconina.
NO20014889L (no) Fremgangsmåte for fremstilling av medisinske midler
HUT62567A (en) Process for producing benzoquinoxaline derivatives and pharmaceutical compositions comprising same as active ingredient
KR930019216A (ko) 종양 치료제

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee